Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma
暂无分享,去创建一个
M. Zauderer | A. Varghese | J. Bendell | V. Wacheck | Melinda D Willard | T. Bauer | S. Callies | E. Alley | E. Capelletto | Anna M. Szpurka | M. D. Willard | Suhyun Kang